<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1341" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1341/" /><meta name="ncbi_pagename" content="Usher Syndrome Type II - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Usher Syndrome Type II - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Usher Syndrome Type II" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/07/21" /><meta name="citation_author" content="Jennifer Lentz" /><meta name="citation_author" content="Bronya Keats" /><meta name="citation_pmid" content="20301515" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1341/" /><meta name="citation_keywords" content="USH2" /><meta name="citation_keywords" content="USH2" /><meta name="citation_keywords" content="Usher Syndrome Type 2" /><meta name="citation_keywords" content="USH2A" /><meta name="citation_keywords" content="USH2C" /><meta name="citation_keywords" content="USH2D" /><meta name="citation_keywords" content="Adhesion G-protein coupled receptor V1" /><meta name="citation_keywords" content="Usherin" /><meta name="citation_keywords" content="Whirlin" /><meta name="citation_keywords" content="ADGRV1" /><meta name="citation_keywords" content="USH2A" /><meta name="citation_keywords" content="WHRN" /><meta name="citation_keywords" content="Usher Syndrome Type II" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Usher Syndrome Type II" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jennifer Lentz" /><meta name="DC.Contributor" content="Bronya Keats" /><meta name="DC.Date" content="2016/07/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1341/" /><meta name="description" content="Usher syndrome type II is characterized by:" /><meta name="og:title" content="Usher Syndrome Type II" /><meta name="og:type" content="book" /><meta name="og:description" content="Usher syndrome type II is characterized by:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1341/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/usher2/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1341/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AF730E041023100000000009A002B.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1341_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1341_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/usher1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/wagner/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1341_"><span class="title" itemprop="name">Usher Syndrome Type II</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: USH2</div><p class="contrib-group"><span itemprop="author">Jennifer Lentz</span>, PhD and <span itemprop="author">Bronya Keats</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1341_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1341_ai__"><div class="contrib half_rhythm"><span itemprop="author">Jennifer Lentz</span>, PhD<div class="affiliation small">Neuroscience Center of Excellence<br />Louisiana State University Health<br />Sciences Center<br />New Orleans, Louisiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cshusl@ztnelj" class="oemail">ude.cshusl@ztnelj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bronya Keats</span>, PhD<div class="affiliation small">Emeritus Professor, Department of Genetics<br />Louisiana State University Health<br />Sciences Center<br />New Orleans, Louisiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.em@staekb" class="oemail">moc.em@staekb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 10, 1999</span>; Last Update: <span itemprop="dateModified">July 21, 2016</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="usher2.Summary" itemprop="description"><h2 id="_usher2_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Usher syndrome type II is characterized by:</p><ul><li class="half_rhythm"><div>Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies;</div></li><li class="half_rhythm"><div>Intact vestibular responses; and</div></li><li class="half_rhythm"><div>Retinitis pigmentosa (RP).</div></li></ul><p>RP is progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Usher syndrome type II is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> using electrophysiologic and subjective tests of hearing and retinal function. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of three genes &#x02013; <i>ADGRV1</i>, <i>WHRN</i> (<i>DFNB31</i>), and <i>USH2A</i> &#x02013; establishes the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Early fitting of hearing aids and speech training.</p><p><i>Surveillance:</i> Routine auditory evaluation to detect changes that may require modifications to hearing aids; routine ophthalmologic evaluation to detect potentially treatable complications such as cataracts.</p><p><i>Agents/circumstances to avoid:</i> Tunnel vision and night blindness can increase the likelihood of accidental injury. Competition in sports requiring a full range of vision may be difficult and possibly dangerous. Progressive loss of peripheral vision impairs the ability to safely drive a car.</p><p><i>Evaluation of relatives at risk:</i> The hearing of at-risk sibs should be assessed as soon after birth as possible to allow early diagnosis and treatment of hearing loss.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Usher syndrome type II is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Each subsequent pregnancy of a couple who has had a child with Usher syndrome type II has a 25% chance of resulting in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child, a 50% chance of resulting in an unaffected child who is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of resulting in an unaffected child who is not a carrier. Prenatal testing is possible for pregnancies at increased risk if the pathogenic variants have been identified in the family.</p></div></div><div id="usher2.Diagnosis"><h2 id="_usher2_Diagnosis_">Diagnosis</h2><div id="usher2.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Usher syndrome type II (USH2) <b>should be suspected</b> in individuals with:</p><ul><li class="half_rhythm"><div>Congenital (i.e., prelingual) sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>);</div></li><li class="half_rhythm"><div>Intact vestibular responses;</div></li><li class="half_rhythm"><div><a href="/books/n/gene/rp-overview/">Retinitis pigmentosa</a> (RP);</div></li><li class="half_rhythm"><div>Normal general health and intellect; otherwise normal physical examination;</div></li><li class="half_rhythm"><div>A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance.</div></li></ul></div><div id="usher2.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of USH2 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the above clinical features and family history. Identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK1341/table/usher2.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figusher2Tmoleculargenetictestingused" rid-ob="figobusher2Tmoleculargenetictestingused">Table 1</a> establishes the diagnosis if clinical features are inconclusive.</p><p>Molecular testing approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>USH2A</i> is performed first, followed by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>ADGRV1</i>, and sequence analysis of <i>WHRN</i> (<i>DFNB31</i>) if <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants are not identified. If only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified with single-gene testing or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> for the same gene is recommended.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes the genes listed in <a class="figpopup" href="/books/NBK1341/table/usher2.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figusher2Tmoleculargenetictestingused" rid-ob="figobusher2Tmoleculargenetictestingused">Table 1</a> and other genes of interest (see <a href="#usher2.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of USH2. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="usher2.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Usher Syndrome Type II</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1341/table/usher2.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__usher2.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Locus</th><th id="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_3" style="text-align:left;vertical-align:middle;">Proportion of USH2 Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4" id="hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4" id="hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADGRV1</i></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">USH2C</td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6.6%-19%&#x000a0;<sup>5</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%&#x000a0;<sup>6</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/49 individuals&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WHRN (DFNB31)</i></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">USH2D</td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0%-9.5%&#x000a0;<sup>5</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%&#x000a0;<sup>6</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>USH2A</i></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">USH2A</td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">57%-79%&#x000a0;<sup>5</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%&#x000a0;<sup>6</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%-9%&#x000a0;<sup>8,&#x000a0;9</sup></td></tr><tr><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>10</sup></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_usher2.T.molecular_genetic_testing_used_1_1_1_4 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_1 hd_h_usher2.T.molecular_genetic_testing_used_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="usher2.TF.1.1"><p class="no_margin">See <a href="/books/NBK1341/#usher2.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="usher2.TF.1.2"><p class="no_margin">See <a href="#usher2.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="usher2.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="usher2.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="usher2.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#usher2.REF.bonnet.2011.21">Bonnet et al [2011]</a>, <a class="bk_pop" href="#usher2.REF.le_quesne_stabej.2012.27">Le Quesne Stabej et al [2012]</a>, <a class="bk_pop" href="#usher2.REF.garc_agarc_a.2013.367">Garc&#x000ed;a-Garc&#x000ed;a et al [2013]</a></p></div></dd><dt>6. </dt><dd><div id="usher2.TF.1.6"><p class="no_margin"><a href="https://grenada.lumc.nl/LOVD2/Usher_montpellier/USHbases.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">grenada<wbr style="display:inline-block"></wbr>​.lumc.nl/LOVD2<wbr style="display:inline-block"></wbr>​/Usher_montpellier/USHbases.html</a></p></div></dd><dt>7. </dt><dd><div id="usher2.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#usher2.REF.hilgert.2009.272">Hilgert et al [2009]</a>, <a class="bk_pop" href="#usher2.REF.besnard.2012.504">Besnard et al [2012]</a>, <a class="bk_pop" href="#usher2.REF.aparisi.2014.168">Aparisi et al [2014]</a></p></div></dd><dt>8. </dt><dd><div id="usher2.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#usher2.REF.bernal.2005.204">Bernal et al [2005]</a>, <a class="bk_pop" href="#usher2.REF.dreyer.2008.451">Dreyer et al [2008]</a>, <a class="bk_pop" href="#usher2.REF.steelestallard.2013.122">Steele-Stallard et al [2013]</a>, <a class="bk_pop" href="#usher2.REF.aparisi.2014.168">Aparisi et al [2014]</a>, <a class="bk_pop" href="#usher2.REF.baux.2014.1179">Baux et al [2014]</a>, <a class="bk_pop" href="#usher2.REF.krawitz.2014.393">Krawitz et al [2014]</a>, <a class="bk_pop" href="#usher2.REF.sodi.2014.1717">Sodi et al [2014]</a>, <a class="bk_pop" href="#usher2.REF.dad.2015.1646">Dad et al [2015]</a></p></div></dd><dt>9. </dt><dd><div id="usher2.TF.1.9"><p class="no_margin">By screening for duplications/deletions, <a class="bk_pop" href="#usher2.REF.steelestallard.2013.122">Steele-Stallard et al [2013]</a> found a second <i>USH2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in 26% (6/23) of individuals for whom only one disease-causing <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> had been found by sequencing.</p></div></dd><dt>10. </dt><dd><div id="usher2.TF.1.10"><p class="no_margin">A fourth <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> associated with Usher syndrome type II has been provisionally mapped to 15q in a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> Tunisian family [<a class="bk_pop" href="#usher2.REF.ben_rebeh.2008.1719">Ben Rebeh et al 2008</a>].</p></div></dd></dl></div></div></div></div></div><div id="usher2.Clinical_Characteristics"><h2 id="_usher2_Clinical_Characteristics_">Clinical Characteristics</h2><div id="usher2.Clinical_Description"><h3>Clinical Description</h3><p><b>Hearing loss</b> in Usher syndrome type II (USH2) is typically <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and bilateral, occurring predominantly in the higher frequencies and ranging from mild to severe. The degree of hearing loss varies within and among families; however, the "sloping" audiogram is characteristic of USH2. The hearing loss may be perceived by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual as progressing over time because speech perception decreases, possibly as a result of diminished vision that interferes with subconscious lip reading.</p><p><b>Clinical variability of the hearing <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b> has been observed. In particular, a few individuals with USH2 have a mild but definite progression of hearing loss that is unrelated to presbycusis. A cross-sectional study of 27 persons with USH2A confirmed by linkage analysis compared hearing threshold against age; significant progression of hearing impairment was observed but at a much slower rate than reported for Usher syndrome type III [<a class="bk_pop" href="#usher2.REF.pennings.2003.525">Pennings et al 2003</a>]. In contrast, in a large study of 125 individuals with Usher syndrome type II, <a class="bk_pop" href="#usher2.REF.reisser.2002.1108">Reisser et al [2002]</a> found no clinically relevant progression of hearing loss over a span of up to 17 years.</p><p><a href="/books/n/gene/rp-overview/"><b>Retinitis pigmentosa</b></a>
<b>(RP)</b> is a progressive, bilateral, symmetric degeneration of the retina that initiates at the periphery; rods (photoreceptors active in the dark-adapted state) are mainly affected first, causing night blindness and constricted visual fields (tunnel vision). Cones (photoreceptors active in the light-adapted state) may also be involved. Visual fields continue to narrow throughout life, but the rate and degree of loss among individuals show considerable intra- and interfamilial variation. A visual field of five to ten degrees is common for a person with Usher syndrome type II age 30-40 years. Visual impairment increases significantly each year [<a class="bk_pop" href="#usher2.REF.iannaccone.2004.784">Iannaccone et al 2004</a>, <a class="bk_pop" href="#usher2.REF.pennings.2004.131">Pennings et al 2004</a>]. However, it is unusual for the typical individual with USH2 to become completely blind, although cataracts sometimes reduce central vision to light/dark perception only.</p><p><b>Tooth enamel dysplasia</b> as well as age of onset of RP may be subtle clinical indicators that can be used in conjunction with linkage analysis to subtype families with USH2 on a research basis. Enamel defects were also reported in a child with <a href="/books/n/gene/usher1/">Usher syndrome type I</a> [<a class="bk_pop" href="#usher2.REF.balmer.2007.57">Balmer &#x00026; Fayle 2007</a>].</p><p><b>Heterozygotes</b> are asymptomatic; however, they may exhibit:</p><ul><li class="half_rhythm"><div>Audiogram anomalies that are not sensitive or specific enough for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> detection;</div></li><li class="half_rhythm"><div>Slightly subnormal electrooculographies (EOGs). The clinical EOG is an electrophysiologic test of function of the oculomotor system. Electrodes are placed on each side of the eye, and the individual, while keeping the head still, moves his or her eyes back and forth alternating between two flashing red lights. The EOG is redundant with the ERG in most retinal disorders. The advantage of the EOG, however, is that the electrodes do not touch the surface of the eye.</div></li></ul></div><div id="usher2.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><a class="bk_pop" href="#usher2.REF.bernal.2005.204">Bernal et al [2005]</a> performed ophthalmologic, vestibular, and audiometric examinations of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in 13 Spanish families with USH2A. In eight families, both pathogenic alleles were identified; in five, only one was identified. No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> were observed within or among families.</p><p><a class="bk_pop" href="#usher2.REF.sadeghi.2004.136">Sadeghi et al [2004]</a> compared serial audiograms of individuals with USH2 who had pathogenic variants in <i>USH2A</i> (group 1) with those of individuals diagnosed with USH2 who did not have pathogenic variants in <i>USH2A</i> (group 2). They found significantly worse thresholds in group 1 than in group 2 after the second decade. These results suggested that the USH2A auditory <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may be different from that of other subtypes of USH2. <a class="bk_pop" href="#usher2.REF.abadie.2012.433">Abadie et al [2012]</a>, however, did not find any significant differences between the audiograms from 88 individuals with pathogenic variants in <i>USH2A</i> and ten individuals with pathogenic variants in <i>ADGRV1</i>.</p><p><a class="bk_pop" href="#usher2.REF.schwartz.2005.734">Schwartz et al [2005]</a> did not observe any <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> between individuals with pathogenic variants in <i>USH2A</i> and those with variants in <i>ADGRV1</i>; however, only three sibs with pathogenic variants in <i>ADGRV1</i> were evaluated. They found a wide spectrum of photoreceptor disease with more rod than cone dysfunction, and both intra- and interfamilial variation for USH2A.</p></div><div id="usher2.Penetrance"><h3>Penetrance</h3><p>Penetrance is 100% in USH2.</p></div><div id="usher2.Nomenclature"><h3>Nomenclature</h3><p><b>USH2B.</b>
<a class="bk_pop" href="#usher2.REF.hmaniaifa.2009.474">Hmani-Aifa et al [2009]</a> provide evidence that the USH2B <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> does not exist; pathogenic variants in <i>ADGRV1</i> (USH2C) have now been found in the Tunisian family originally used to map USH2B.</p></div><div id="usher2.Prevalence"><h3>Prevalence</h3><p>The prevalence of Usher syndrome in the general US population has been conservatively estimated at 4.4:100,000. However, a study of children with hearing loss in Oregon found that 11% had pathogenic variants in genes associated with Usher syndrome and estimated that the prevalence may be as high as 1:6,000 [<a class="bk_pop" href="#usher2.REF.kimberling.2010.512">Kimberling et al 2010</a>].</p><p>Usher syndrome has been estimated to be responsible for 3%-6% of all childhood deafness and approximately 50% of all deaf-blindness. These estimates were made prior to 1989, when <a class="bk_pop" href="#usher2.REF.m_ller.1989.73">M&#x000f6;ller et al [1989]</a> subdivided Usher syndrome into Usher syndrome type I (USH1) and type II (USH2), and Usher syndrome type III (USH3) had not yet been recognized. The specialized educational requirements of the congenitally deaf have historically rendered the population with USH1 more accessible for study by researchers. Persons with USH2 or USH3 communicate orally and are mainstreamed into regular schools; thus, the prevalence of USH2 and USH3 in the general population cannot be estimated as accurately as that of USH1. Often, persons with USH2 are not diagnosed until early adulthood, when progressive RP becomes debilitating.</p><p>The prevalence of Usher syndrome in Heidelberg, Germany and its suburbs has been calculated to be 6.2:100,000 [<a class="bk_pop" href="#usher2.REF.spandau.2002.495">Spandau &#x00026; Rohrschneider 2002</a>]. In that study, the ratio of USH1 to USH2 was 1:3.</p></div></div><div id="usher2.Genetically_Related_Allelic_Disor"><h2 id="_usher2_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p><b><i>ADGRV1</i> (<i>GPR98</i>, <i>VLGR1</i>).</b> A pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant in <i>ADGRV1</i> was found in one of 48 families with febrile seizures [<a class="bk_pop" href="#usher2.REF.nakayama.2002.654">Nakayama et al 2002</a>], suggesting that such variants are unlikely to be a common cause of febrile seizures in humans. However, the Frings mouse, which is prone to audiogenic seizures, has a spontaneous mutation of the mouse ortholog <i>Adgrv1</i> [<a class="bk_pop" href="#usher2.REF.skradski.2001.537">Skradski et al 2001</a>].</p><p><b><i>WHRN</i> (<i>DFNB31</i>).</b> Pathogenic variants in <i>WHRN</i> are also associated with nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> hearing loss [<a class="bk_pop" href="#usher2.REF.mburu.2003.421">Mburu et al 2003</a>, <a class="bk_pop" href="#usher2.REF.tlili.2005.503">Tlili et al 2005</a>].</p><p><b><i>USH2A.</i></b> Pathogenic variants in <i>USH2A</i> are also a common cause of nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> retinitis pigmentosa (arRP) (see <a href="/books/n/gene/rp-overview/">Retinitis Pigmentosa Overview</a>). <a class="bk_pop" href="#usher2.REF.seyedahmadi.2004.167">Seyedahmadi et al [2004]</a> found <i>USH2A</i> variants in 12% of individuals with arRP.</p><p><a class="bk_pop" href="#usher2.REF.rivolta.2000.1975">Rivolta et al [2000]</a> observed a novel <i>USH2A</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, <a class="figpopup" href="/books/NBK1341/table/usher2.T.ush2a_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figusher2Tush2apathogenicvariantsdiscu" rid-ob="figobusher2Tush2apathogenicvariantsdiscu">p.Cys759Phe</a>, in individuals with arRP; many of these individuals had normal hearing even when their second <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was known to be associated with Usher syndrome type II (including the common <a class="figpopup" href="/books/NBK1341/table/usher2.T.ush2a_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figusher2Tush2apathogenicvariantsdiscu" rid-ob="figobusher2Tush2apathogenicvariantsdiscu">p.Glu767SerfsTer21</a> variant). However, homozygosity of <a class="figpopup" href="/books/NBK1341/table/usher2.T.ush2a_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figusher2Tush2apathogenicvariantsdiscu" rid-ob="figobusher2Tush2apathogenicvariantsdiscu">p.Cys759Phe</a> in unaffected individuals indicates that this pathogenic variant may not be sufficient to cause arRP [<a class="bk_pop" href="#usher2.REF.bernal.2003.e8">Bernal et al 2003</a>]. This variant was not found in Israeli individuals with arRP, but compound heterozygotes for an <i>USH2A</i> pathogenic variant and other novel sequence changes in exons 22-72 were reported, in particular for <a class="figpopup" href="/books/NBK1341/table/usher2.T.ush2a_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figusher2Tush2apathogenicvariantsdiscu" rid-ob="figobusher2Tush2apathogenicvariantsdiscu">p.Arg4674Gly</a> [<a class="bk_pop" href="#usher2.REF.kaiserman.2008.571">Kaiserman et al 2008</a>].</p></div><div id="usher2.Differential_Diagnosis"><h2 id="_usher2_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Nonsyndromic hearing loss (NSHL).</b> Often, a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sib is thought to have NSHL (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness Overview</a>) until the oldest is diagnosed with RP (see <a href="/books/n/gene/rp-overview/">Retinitis Pigmentosa Overview</a>). Subsequent visual evaluation reveals the presymptomatic early stages of RP in younger affected sibs. Pathogenic variants in genes for NSHL and RP can be inherited independently by a single individual whose symptoms mimic those of Usher syndrome [<a class="bk_pop" href="#usher2.REF.fakin.2012.71">Fakin et al 2012</a>]. NSHL and RP are both relatively common, with frequencies at 1:1,000 and 1:4,000, respectively. Larger families lessen the statistical probability of this occurrence, because at least one sib is likely to inherit one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> without the other.</p><p><a href="/books/n/gene/usher1/"><b>Usher syndrome type I</b></a>
<b>(USH1)</b> is characterized by <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> bilateral profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset RP. One of the most important clinical distinctions between USH1 and USH2 is that children with USH1 are usually delayed in walking until age 18 months to two years because of vestibular involvement, whereas children with USH2 usually begin walking at approximately one year of age.</p><p><b>Usher syndrome type III (USH3)</b> (OMIM <a href="http://omim.org/entry/276902" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">276902</a>, <a href="http://omim.org/entry/614504" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614504</a>) is characterized by postlingual, progressive sensorineural hearing loss, late-onset RP, and variable impairment of vestibular function [<a class="bk_pop" href="#usher2.REF.plantinga.2005.79">Plantinga et al 2005</a>]. Pathogenic variants in <i>CLRN1</i> (OMIM <a href="http://omim.org/entry/606397" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606397</a>) or <i>HARS1</i> (OMIM <a href="http://omim.org/entry/142810" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">142810</a>) are causative [<a class="bk_pop" href="#usher2.REF.joensuu.2001.673">Joensuu et al 2001</a>, <a class="bk_pop" href="#usher2.REF.v_stinsalo.2011.30">V&#x000e4;stinsalo et al 2011</a>, <a class="bk_pop" href="#usher2.REF.puffenberger.2012.e28936">Puffenberger et al 2012</a>]. Persons with USH3 may have symptoms that mimic USH2, especially early in the progression of the disease [<a class="bk_pop" href="#usher2.REF.pennings.2003.525">Pennings et al 2003</a>].</p><p><a href="/books/n/gene/ddon/"><b>Deafness-dystonia-optic neuronopathy</b></a>
<b>(DDON).</b> Males with DDON have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and dementia beginning at approximately age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment appears to be constant in age of onset and progression, whereas the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia. DDON syndrome occurs as either a single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> disorder resulting from a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TIMM8A</i> or a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a> at Xq22. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</p><p>Individuals with DDON syndrome may initially be suspected of having Usher syndrome because the hearing impairment in DDON syndrome may be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and the hearing impairment in Usher syndrome type II is occasionally progressive [<a class="bk_pop" href="#usher2.REF.sadeghi.2004.136">Sadeghi et al 2004</a>].</p><p><b>Other.</b> Viral infections, diabetic neuropathy, and syndromes involving <a href="/books/n/gene/mt-overview/">mitochondrial defects</a> can all produce concurrent symptoms of hearing loss and RP.</p></div><div id="usher2.Management"><h2 id="_usher2_Management_">Management</h2><div id="usher2.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Usher syndrome type II (USH2), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div><b>Audiology.</b> Otoscopy, puretone audiometry, assessment of speech perception, and, in some individuals, auditory brain stem response (ABR) and distortion product otoacoustic emission (DPOAE)</div></li><li class="half_rhythm"><div><b>Vestibular function.</b> Rotary chair, calorics, electronystagmography, and computerized posturography</div></li><li class="half_rhythm"><div><b>Ophthalmology.</b> Funduscopy, visual acuity, visual field (Goldmann perimetry), electroretinography (ERG)</div></li><li class="half_rhythm"><div><b>Other.</b> Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="usher2.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Hearing.</b> Hearing aids are helpful. Young children can benefit from early fitting of hearing aids and speech training to normalize language.</p><p>Environmental trauma (e.g., noise) or a genetic susceptibility (e.g., presbycusis) in addition to the <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, stable deficit of USH2 may combine to produce severe-to-profound hearing loss in older individuals with USH2; in such individuals, cochlear implantation may be warranted.</p><p><b>Vision.</b> See <a href="/books/n/gene/rp-overview/">Retinitis Pigmentosa Overview</a>, Management.</p><p>Tunnel vision and night blindness can increase the likelihood of accidental injury.</p></div><div id="usher2.Surveillance"><h3>Surveillance</h3><p>Routine auditory evaluation is recommended in order to detect changes that may require modifications to hearing aids.</p><p>Routine ophthalmologic evaluation is recommended in order to detect potentially treatable complications such as cataracts.</p></div><div id="usher2.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Competition in various sports requiring a full range of vision may be difficult and possibly dangerous.</p><p>Progressive loss of peripheral vision impairs the ability to safely drive a car.</p></div><div id="usher2.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate all sibs at risk for Usher syndrome type II as soon after birth as possible to allow early support and management of the child and the family. Evaluations include:</p><ul><li class="half_rhythm"><div>Audiology. ABR, DPOAE</div></li><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known</div></li></ul><p>See <a href="#usher2.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to evaluation of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="usher2.Pregnancy_Management"><h3>Pregnancy Management</h3><p>High-dose vitamin A supplementation should not be used by <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> pregnant women, as large doses of vitamin A (doses above the RDA for pregnant or lactating women) may be teratogenic to the developing fetus (see <a href="#usher2.Other">Other</a>).</p></div><div id="usher2.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="usher2.Other"><h3>Other</h3><p><b>Vitamin A supplements.</b> Although treatment with vitamin A palmitate may limit the progression of RP in some persons, no formal studies have evaluated its effectiveness in Usher syndrome type II. Vitamin A is fat soluble and not excreted in the urine. Therefore, high-dose vitamin A should be used only under the direction of a physician because of the need to monitor for harmful side effects, such as hepatotoxicity. Of note, the studies by <a class="bk_pop" href="#usher2.REF.berson.1993.761">Berson et al [1993]</a> were performed on individuals older than age 18 years because of the unknown effects of high-dose vitamin A on children.</p><p><b>Lutein supplements.</b> Oral administration of lutein (20 mg/d) for six months had no effect on central vision; however, long-term effects are unknown [<a class="bk_pop" href="#usher2.REF.aleman.2001.1873">Aleman et al 2001</a>].</p></div></div><div id="usher2.Genetic_Counseling"><h2 id="_usher2_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="usher2.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Usher syndrome type II (USH2) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="usher2.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an individual with USH2 are obligate heterozygotes (i.e., carriers of one <i>ADGRV1</i>, <i>WHRN</i> (<i>DFNB31</i>), or <i>USH2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with USH2 are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ADGRV1</i>, <i>WHRN</i> (<i>DFNB31</i>), or <i>USH2A</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ADGRV1</i>, <i>WHRN</i> (<i>DFNB31</i>), or <i>USH2A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="usher2.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ADGRV1</i>, <i>WHRN</i> (<i>DFNB31</i>), or <i>USH2A</i> pathogenic variants in the family.</p></div><div id="usher2.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#usher2.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="usher2.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ADGRV1</i>, <i>WHRN</i> (<i>DFNB31</i>), or <i>USH2A</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for USH2 are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="usher2.Resources"><h2 id="_usher2_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Usher%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Usher syndrome</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=ushersyndrometypei" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Usher syndrome</a></div></li><li class="half_rhythm"><div><b>Usher Syndrome Coalition</b></div><div><b>Phone:</b> 978-637-2625; 617-951-9542</div><div><b>Email:</b> k.vasi@usher-syndrome.org; m.dunning@lek.com</div><div><a href="http://www.usher-syndrome.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.usher-syndrome.org</a></div></li><li class="half_rhythm"><div><b>Alexander Graham Bell Association for the Deaf and Hard of Hearing</b></div><div>3417 Volta Place Northwest</div><div>Washington DC 20007</div><div><b>Phone:</b> 866-337-5220 (toll-free); 202-337-5220; 202-337-5221 (TTY)</div><div><b>Fax:</b> 202-337-8314</div><div><b>Email:</b> info@agbell.org</div><div><a href="http://www.agbell.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Listening and Spoken Language Knowledge Center</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>BabyHearing.org</b></div><div><i>This site, developed with support from the National Institute on Deafness and Other Communication Disorders, provides information about newborn hearing screening and hearing loss.</i></div><div><a href="http://www.babyhearing.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.babyhearing.org</a></div></li><li class="half_rhythm"><div><b>Ciliopathy Alliance</b></div><div>United Kingdom</div><div><b>Phone:</b> 44 20 7387 0543</div><div><a href="http://www.ciliopathyalliance.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ciliopathyalliance.org</a></div></li><li class="half_rhythm"><div><b>Foundation Fighting Blindness</b></div><div>7168 Columbia Gateway Drive</div><div>Suite 100</div><div>Columbia MD 21046</div><div><b>Phone:</b> 800-683-5555 (toll-free); 800-683-5551 (toll-free TDD); 410-423-0600</div><div><b>Email:</b> info@fightblindness.org</div><div><a href="https://www.fightingblindness.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fightingblindness.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li><li class="half_rhythm"><div><b>SENSE</b></div><div>101 Pentonville Road</div><div>London N1 9LG</div><div>United Kingdom</div><div><b>Phone:</b> 0845 127 0060 (voice); 0845 127 0062 (textphone)</div><div><b>Fax:</b> 0845 127 0061</div><div><b>Email:</b> info@sense.org.uk</div><div><a href="http://www.sense.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.sense.org</a></div></li><li class="half_rhythm"><div><b>Usher Syndrome Registry</b></div><div>Usher Syndrome Coalition</div><div><b>Phone:</b> 978-637-2625</div><div><b>Email:</b> k.vasi@usher-syndrome.org</div><div><a href="https://www.usher-registry.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.usher-registry.org</a></div></li></ul></div><div id="usher2.Molecular_Genetics"><h2 id="_usher2_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="usher2.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Usher Syndrome Type II: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1341/table/usher2.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__usher2.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_usher2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_usher2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_usher2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_usher2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_usher2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_usher2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_usher2.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_usher2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">USH2A</td><td headers="hd_b_usher2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7399" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>USH2A</i></a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7399" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q41</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75445" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Usherin</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/USH2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">USH2A @ LOVD</a><br /><a href="http://www.retina-international.org/files/sci-news/ush2amut.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Retina International Mutations of the USH2a Gene</a><br /><a href="https://research.cchmc.org/LOVD2/home.php?select_db=USH2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (USH2A)</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=USH2A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">USH2A</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=USH2A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">USH2A</a></td></tr><tr><td headers="hd_b_usher2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">USH2C</td><td headers="hd_b_usher2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/84059" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ADGRV1</i></a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=84059" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5q14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8WXG9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Adhesion G-protein coupled receptor V1</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/GPR98" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GPR98 @ USHbases</a><br /><a href="https://research.cchmc.org/LOVD2/home.php?select_db=GPR98" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (GPR98)</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ADGRV1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADGRV1</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ADGRV1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADGRV1</a></td></tr><tr><td headers="hd_b_usher2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">USH2D</td><td headers="hd_b_usher2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/25861" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>WHRN</i></a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=25861" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q32</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9P202" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Whirlin</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/WHRN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WHRN @ USHbases (DFNB31)</a><br /><a href="https://research.cchmc.org/LOVD2/home.php?select_db=DFNB31" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (DFNB31)</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=WHRN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WHRN</a></td><td headers="hd_b_usher2.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=WHRN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">WHRN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="usher2.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="usher2.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Usher Syndrome Type II (<a href="/omim/276901,602851,605472,607928,608400,611383" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1341/table/usher2.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__usher2.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/276901" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">276901</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">USHER SYNDROME, TYPE IIA; USH2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602851" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602851</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADHESION G PROTEIN-COUPLED RECEPTOR V1; ADGRV1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605472" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605472</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">USHER SYNDROME, TYPE IIC; USH2C</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607928" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607928</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WHIRLIN; WHRN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">USH2A GENE; USH2A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611383" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611383</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">USHER SYNDROME, TYPE IID; USH2D</td></tr></tbody></table></div></div><div id="usher2.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The proteins associated with <a href="/books/n/gene/usher1/">USH1</a> and USH2 interact with one another. Both harmonin (product of <i>USH1C</i>) and whirlin contain PDZ domains that play a role in these interactions. If any one of the molecules in this "Usher interactome" is nonfunctional or absent, sensorineural degeneration occurs in the inner ear and the retina [<a class="bk_pop" href="#usher2.REF.adato.2005.3921">Adato et al 2005</a>, <a class="bk_pop" href="#usher2.REF.reiners.2006.97">Reiners et al 2006</a>, <a class="bk_pop" href="#usher2.REF.van_wijk.2006.751">van Wijk et al 2006</a>, <a class="bk_pop" href="#usher2.REF.maerker.2008.71">Maerker et al 2008</a>]. Another PDZ <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing protein, PDZD7, was identified as a result of a study of a child with nonsyndromic sensorineural hearing loss and a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> reciprocal <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a>; protein-protein interaction studies indicated that PDZD7 is a part of the Usher protein network [<a class="bk_pop" href="#usher2.REF.schneider.2009.655">Schneider et al 2009</a>]. Pathogenic variants in <i>PDZD7</i> have not yet been shown to cause Usher syndrome, but it has been suggested that <i>PDZD7</i> pathogenic variants may act as modifiers of the retinal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in individuals with USH2A. Additionally, an individual with USH2 and <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>USH2A</i> and <i>PDZD7</i> and another <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with heterozygous variants in <i>ADGRV1</i> and <i>PDZD7</i> were reported, leading to the suggestion of <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> inheritance [<a class="bk_pop" href="#usher2.REF.ebermann.2010.1812">Ebermann et al 2010</a>].</p><p>Whirlin interacts in vivo with usherin and ADGRV1, suggesting that these three proteins function as a multiprotein complex in both the stereocilia of the cochlear hair cells and the periciliary membrane complex of the retinal photoreceptor cells [<a class="bk_pop" href="#usher2.REF.yang.2010.e1000955">Yang et al 2010</a>].</p><div id="usher2.ADGRV1_formerly_GPR98_or_VLGR1"><h4><i>ADGRV1</i> (formerly <i>GPR98</i> or <i>VLGR1</i>)</h4><p><b>Gene structure.</b>
<i>ADGRV1</i> spans more than 600 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA and contains 90 exons (<a href="/nuccore/NM_032119.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_032119.3</a>). It is expressed predominantly in the central nervous system during development. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1341/#usher2.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<a class="bk_pop" href="#usher2.REF.weston.2004.357">Weston et al [2004]</a> identified four pathogenic variants in three families with Usher syndrome type 2C; all of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members in these families were female. Several males with <i>ADGRV1</i> pathogenic variants, including a large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in members of an Iranian family [<a class="bk_pop" href="#usher2.REF.hilgert.2009.272">Hilgert et al 2009</a>], have now been reported [<a class="bk_pop" href="#usher2.REF.ebermann.2009.277">Ebermann et al 2009</a>]; the total number of known variants is currently about 100.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The protein ADGRV1 belongs to a subgroup of the large N-terminal family B seven-transmembrane receptors, all of which have a G-protein-coupled proteolysis site. The proteins encoded by <i>ADGRV1</i> and <i>USH2A</i> have quite similar pentraxin (PTX) homology domains, suggesting that they may share an affinity for a common binding partner. Also, the motif architecture of the protein encoded by <i>ADGRV1</i> is very like that of cadherins, two of which are encoded by genes associated with <a href="/books/n/gene/usher1/">Usher syndrome type I</a> (<i>CDH23</i> and <i>PCDH15</i>). There are three <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> (a, b, c) of ADGRV1, all of which are expressed in fetal retina and cochlea. Isoform a is the smallest and least abundant, with 1967 amino acids. The longest, isoform b (<a href="/protein/NP_115495.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_115495.3</a>), has 6306 amino acids with a predicted molecular weight of 692 kd; it is the largest known cell-surface receptor protein and is the predominant isoform in both the retina and the inner ear [<a class="bk_pop" href="#usher2.REF.zou.2011.2343">Zou et al 2011</a>]. Isoform c has 2296 amino acids [<a class="bk_pop" href="#usher2.REF.mcmillan.2002.785">McMillan et al 2002</a>]. The very large extracellular portion of ADGRV1 isoform b has 35 CalX-&#x003b2; modules, and the C-terminal residues correspond to the consensus motif for a PDZ-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><p><b>Abnormal protein product.</b> See <a href="#usher2.Molecular_Pathogenesis">Molecular Pathogenesis</a>. Most of the <i>ADGRV1</i> pathogenic variants reported in individuals with USH2 result in a truncated protein [<a class="bk_pop" href="#usher2.REF.besnard.2012.504">Besnard et al 2012</a>].</p></div><div id="usher2.WHRN_DFNB31"><h4><i>WHRN</i> (<i>DFNB31</i>)</h4><p><b>Gene structure.</b> The longest <i>WHRN</i> transcript (<a href="/nuccore/NM_015404.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015404.3</a>) contains 12 exons and spans 101 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequence. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1341/#usher2.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<a class="bk_pop" href="#usher2.REF.ebermann.2007.203">Ebermann et al [2007]</a> identified a <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 and an exon 2 splice donor site variant in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> members of a German family with USH2. However, no evidence of causal <i>WHRN</i> variants was found in a study of 195 individuals with Usher syndrome, suggesting that the percentage of people with Usher syndrome type 2D is small [<a class="bk_pop" href="#usher2.REF.aller.2010.495">Aller et al 2010</a>]. To date, fewer than 20 USH2-causing <i>WHRN</i> variants have been reported.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Whirlin is a scaffold protein and has a structure similar to harmonin (the <i>USH1C</i> gene product) with up to three PDZ domains and a proline-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. It has multiple <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, including the C-terminal isoform (<a href="/protein/NP_001077354.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001077354.2</a>, 524 amino acids) and the long isoform (<a href="/protein/NP_056219.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056219.3</a>, 907 amino acids). Both of these isoforms are found in the cochlea; only the long isoform is expressed in the retina.</p><p><b>Abnormal protein product.</b> See <a href="#usher2.Molecular_Pathogenesis">Molecular Pathogenesis</a>. All pathogenic variants associated with Usher syndrome type 2D affect only the long isoform of whirlin. The whirlin knockout mouse has early-onset hearing loss and retinal degeneration starting at age 28 months, and its photoreceptors and hair cells show mislocalization and reduced expression of both usherin and protein ADGRV1. Returning whirlin to this mouse via <a class="def" href="/books/n/gene/glossary/def-item/gene-therapy/">gene therapy</a> restores normal localization and expression levels of all three proteins [<a class="bk_pop" href="#usher2.REF.yang.2010.e1000955">Yang et al 2010</a>, <a class="bk_pop" href="#usher2.REF.zou.2011.2343">Zou et al 2011</a>].</p></div><div id="usher2.USH2A"><h4><i>USH2A</i></h4><p><b>Gene structure.</b>
<i>USH2A</i> spans approximately 790 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA and contains 72 exons [<a class="bk_pop" href="#usher2.REF.van_wijk.2004.738">van Wijk et al 2004</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b> and <a href="/books/NBK1341/#usher2.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 600 <i>USH2A</i> pathogenic variants have been documented. Initially it was thought that most variants were in the 21 exons originally described, with p.Glu767SerfsTer21 being the most common (16%) [<a class="bk_pop" href="#usher2.REF.eudy.1998.1753">Eudy et al 1998</a>, <a class="bk_pop" href="#usher2.REF.adato.2000.388">Adato et al 2000</a>, <a class="bk_pop" href="#usher2.REF.dreyer.2000.500">Dreyer et al 2000</a>, <a class="bk_pop" href="#usher2.REF.weston.2000.1199">Weston et al 2000</a>, <a class="bk_pop" href="#usher2.REF.leroy.2001.503">Leroy et al 2001</a>, <a class="bk_pop" href="#usher2.REF.n_jera.2002.76">N&#x000e1;jera et al 2002</a>]. However, many pathogenic variants have now been reported in exons 22-72 and in the flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> sequences of all exons [<a class="bk_pop" href="#usher2.REF.baux.2007.781">Baux et al 2007</a>, <a class="bk_pop" href="#usher2.REF.baux.2014.1179">Baux et al 2014</a>]. A deep intronic variant resulting in activation of a pseudoexon has also been found, indicating that RNA analysis may be informative in individuals for whom only one variant is identified by <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> [<a class="bk_pop" href="#usher2.REF.vach_.2012.104">Vach&#x000e9; et al 2012</a>]. Four <i>USH2A</i> variants account for 64% of mutated alleles underlying USH2 in the non-<a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> population [<a class="bk_pop" href="#usher2.REF.auslender.2008.289">Auslender et al 2008</a>]. Studies from China and Japan suggest that the spectrum of pathogenic variants may differ between Asian and European populations [<a class="bk_pop" href="#usher2.REF.nakanishi.2011.484">Nakanishi et al 2011</a>, <a class="bk_pop" href="#usher2.REF.xu.2011.1537">Xu et al 2011</a>].</p><div id="usher2.T.ush2a_pathogenic_variants_discu" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>USH2A</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1341/table/usher2.T.ush2a_pathogenic_variants_discu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__usher2.T.ush2a_pathogenic_variants_discu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2276G&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys759Phe</td><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?val=NM_206933.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_206933<wbr style="display:inline-block"></wbr>​.1</a>&#x000a0;<sup>2</sup><br /><a href="/entrez/viewer.fcgi?val=NP_996816.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_996816<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2299delG&#x000a0;<sup>1</sup></td><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu767SerfsTer21</td></tr><tr><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.14020A&#x0003e;G&#x000a0;<sup>1</sup></td><td headers="hd_h_usher2.T.ush2a_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg4674Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="usher2.TF.2.1"><p class="no_margin">See <a href="#usher2.Genetically_Related_Allelic_Disor">Genetically Related Disorders</a>.</p></div></dd><dt>2. </dt><dd><div id="usher2.TF.2.2"><p class="no_margin">Longest transcript variant of 72 exons</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The originally described 21 exons of <i>USH2A</i> (<a href="/nuccore/NM_007123.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_007123.5</a>) encode a protein of 1,546 amino acids. An additional 51 novel exons were subsequently identified, with the longest ORF extending from <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 to 72 (<a href="/entrez/viewer.fcgi?val=NM_206933.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_206933.1</a>), and encoding a putative protein of 5,202 amino acids [<a class="bk_pop" href="#usher2.REF.van_wijk.2004.738">van Wijk et al 2004</a>]. Expression of both the short and long <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> is highest in the adult retina, with the long form being the most predominant, and specifically localized to the photoreceptor cells. It is also found in developing cochlear hair cells, but disappears by about postnatal day 15 [<a class="bk_pop" href="#usher2.REF.liu.2007.4413">Liu et al 2007</a>].</p><p>The short isoform (<a href="/protein/NP_009054.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_009054.5</a>) of usherin has four readily identifiable domains observed in extracellular matrix or cell adhesion proteins: a laminin G-like jellyroll fold (LamG/TSPN/PTX), also found in thrombospondins and pentraxins, laminin type VI (LN), ten laminin epidermal growth factor (LE), and four fibronectin type-III (FN3) repeats; the long isoform (<a href="/protein/NP_996816.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_996816.2</a>) has an additional 28 FN3 repeats, as well as two laminin G (LamG) domains. It is predicted to have an outside-in transmembrane region followed by an intracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that includes a PDZ-binding domain at its C-terminal end [<a class="bk_pop" href="#usher2.REF.van_wijk.2004.738">van Wijk et al 2004</a>]. Proteins with LamG domains are involved in neuronal growth, patterning, and calcium-mediated ligand binding. The LN module of usherin has the most homology with the netrins, which are chemoattractant matrix molecules involved in nerve fiber guidance. Arrays of LE domains form rod-like tertiary structures that may provide a rigid spacer between two functional domains. FN domains in other proteins form beta-pleated sheets that bind heparin and integrin molecules. Usherin studies show colocalization with and binding to the extracellular basement membrane protein, type IV collagen, with a relatively broad tissue distribution [<a class="bk_pop" href="#usher2.REF.bhattacharya.2002.1">Bhattacharya et al 2002</a>, <a class="bk_pop" href="#usher2.REF.pearsall.2002.55">Pearsall et al 2002</a>, <a class="bk_pop" href="#usher2.REF.bhattacharya.2004.233">Bhattacharya et al 2004</a>].</p><p><b>Abnormal protein product.</b> See <a href="#usher2.Molecular_Pathogenesis">Molecular Pathogenesis</a>. The <i>Ush2a</i> knockout mouse model has stable moderate hearing loss and develops progressive photoreceptor degeneration after age ten months [<a class="bk_pop" href="#usher2.REF.liu.2007.4413">Liu et al 2007</a>].</p></div></div></div><div id="usher2.References"><h2 id="_usher2_References_">References</h2><div id="usher2.Published_Guidelines__Consensus_S"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="usher2.REF1">American College of Medical Genetics. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic evaluation of congenital hearing loss expert panel. Available <a href="/pmc/articles/PMC3110944/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2002. Accessed 7-19-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF2">American College of Medical Genetics. Statement on universal newborn hearing screening. Available <a href="http://www.acmg.net/PDFLibrary/Universal-Newborn-Hearing-Screening.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2000. Accessed 7-19-19.</div></li></ul></div><div id="usher2.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.abadie.2012.433">Abadie C, Blanchet C, Baux D, Larrieu L, Besnard T, Ravel P, Biboulet R, Hamel C, Malcolm S, Mondain M, Claustres M, Roux AF. Audiological findings in 100 USH2 patients. <span><span class="ref-journal">Clin Genet. </span>2012;<span class="ref-vol">82</span>:433–8.</span> [<a href="/pubmed/21895633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21895633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.adato.2005.3921">Adato A, Lef&#x000e8;vre G, Delprat B, Michel V, Michalski N, Chardenoux S, Weil D, El-Amraoui A, Petit C. Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:3921–32.</span> [<a href="/pubmed/16301217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16301217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.adato.2000.388">Adato A, Weston MD, Berry A, Kimberling WJ, Bonne-Tamir A. Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">15</span>:388.</span> [<a href="/pubmed/10738000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10738000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.aleman.2001.1873">Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2001;<span class="ref-vol">42</span>:1873–81.</span> [<a href="/pubmed/11431456" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11431456</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.aller.2010.495">Aller E, Jaijo T, van Wijk E, Ebermann I, Kersten F, Garc&#x000ed;a-Garc&#x000ed;a G, Voesenek K, Aparisi MJ, Hoefsloot L, Cremers C, Diaz-Llopis M, Pennings R, Bolz H, Kremer H, Mill&#x000e1;n JM. Sequence variants of the DFNB31 gene among Usher syndrome patients of diverse origin. <span><span class="ref-journal">Mol Vis. </span>2010;<span class="ref-vol">16</span>:495–500.</span> [<a href="/pmc/articles/PMC2845667/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2845667</span></a>] [<a href="/pubmed/20352026" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20352026</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.aparisi.2014.168">Aparisi MJ, Aller E, Fuster-Garcia C, Garcia-Garcia G, Rodrigo R, Vazquez-Manrique RP, Blanco-Kelly F, Ayuso C, Roux AF, Jaijo T, Millan JM. Targeted next generation sequencing for molecular diagnosis of Usher syndrome. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:168.</span> [<a href="/pmc/articles/PMC4245769/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4245769</span></a>] [<a href="/pubmed/25404053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25404053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.auslender.2008.289">Auslender N, Bandah D, Rizel L, Behar DM, Shohat M, Banin E, Allon-Shalev S, Sharony R, Sharon D, Ben-Yosef T. Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews. <span><span class="ref-journal">Genet Test. </span>2008;<span class="ref-vol">12</span>:289–94.</span> [<a href="/pubmed/18452394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18452394</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.balmer.2007.57">Balmer R, Fayle SA. Enamel defects and ectopic eruption in a child with Usher syndrome and a cochlear implant. <span><span class="ref-journal">Int J Paediatr Dent. </span>2007;<span class="ref-vol">17</span>:57–61.</span> [<a href="/pubmed/17181580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17181580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.baux.2014.1179">Baux D, Blanchet C, Hamel C, Meunier I, Larrieu L, Faugere V, Vache C, Castorina P, Puech B, Bonneau D, Malcolm S, Claustres M, Roux AF. Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:1179–86.</span> [<a href="/pubmed/24944099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24944099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.baux.2007.781">Baux D, Larrieu L, Blanchet C, Hamel C, Ben Salah S, Vielle A, Gilbert-Dussardier B, Holder M, Calvas P, Philip N, Edery P, Bonneau D, Claustres M, Malcolm S, Roux AF. Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:781–9.</span> [<a href="/pubmed/17405132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17405132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.ben_rebeh.2008.1719">Ben Rebeh I, Benzina Z, Dhouib H, Hadjamor I, Amyere M, Ayadi L, Turki K, Hammami B, Kmiha N, Kammoun H, Hakim B, Charfedine I, Vikkula M, Ghorbel A, Ayadi H, Masmoudi S. Identification of candidate regions for a novel Usher syndrome type II locus. <span><span class="ref-journal">Mol Vis. </span>2008;<span class="ref-vol">14</span>:1719–26.</span> [<a href="/pmc/articles/PMC2538493/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2538493</span></a>] [<a href="/pubmed/18806881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18806881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.bernal.2003.e8">Bernal S, Ayuso C, Anti&#x000f1;olo G, Gimenez A, Borrego S, Trujillo MJ, Marcos I, Calaf M, Del Rio E, Baiget M. Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:e8.</span> [<a href="/pmc/articles/PMC1735247/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735247</span></a>] [<a href="/pubmed/12525556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12525556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.bernal.2005.204">Bernal S, Med&#x000e0; C, Solans T, Ayuso C, Garcia-Sandoval B, Valverde D, Del Rio E, Baiget M. Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype--phenotype correlation. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:204–14.</span> [<a href="/pubmed/16098008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16098008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.berson.1993.761">Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, Willett W. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. <span><span class="ref-journal">Arch Ophthalmol. </span>1993;<span class="ref-vol">111</span>:761–72.</span> [<a href="/pubmed/8512476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8512476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.besnard.2012.504">Besnard T, Vach&#x000e9; C, Baux D, Larrieu L, Abadie C, Blanchet C, Odent S, Blanchet P, Calvas P, Hamel C, Dollfus H, Lina-Granade G, Lespinasse J, David A, Isidor B, Morin G, Malcolm S, Tuffery-Giraud S, Claustres M, Roux AF. Non-USH2A mutations in USH2 patients. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:504–10.</span> [<a href="/pubmed/22147658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22147658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.bhattacharya.2004.233">Bhattacharya G, Kalluri R, Orten DJ, Kimberling WJ, Cosgrove D. A domain-specific usherin/collagen IV interaction may be required for stable integration into the basement membrane superstructure. <span><span class="ref-journal">J Cell Sci. </span>2004;<span class="ref-vol">117</span>:233–42.</span> [<a href="/pubmed/14676276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14676276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.bhattacharya.2002.1">Bhattacharya G, Miller C, Kimberling WJ, Jablonski MM, Cosgrove D. Localization and expression of usherin: a novel basement membrane protein defective in people with Usher's syndrome type IIa. <span><span class="ref-journal">Hear Res. </span>2002;<span class="ref-vol">163</span>:1–11.</span> [<a href="/pubmed/11788194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11788194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.bonnet.2011.21">Bonnet C, Grati M, Marlin S, Levilliers J, Hardelin JP, Parodi M, Niasme-Grare M, Zelenika D, D&#x000e9;l&#x000e9;pine M, Feldmann D, Jonard L, El-Amraoui A, Weil D, Delobel B, Vincent C, Dollfus H, Eliot MM, David A, Calais C, Vigneron J, Montaut-Verient B, Bonneau D, Dubin J, Thauvin C, Duvillard A, Francannet C, Mom T, Lacombe D, Duriez F, Drouin-Garraud V, Thuillier-Obstoy MF, Sigaudy S, Frances AM, Collignon P, Challe G, Couderc R, Lathrop M, Sahel JA, Weissenbach J, Petit C, Denoyelle F. Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2011;<span class="ref-vol">6</span>:21.</span> [<a href="/pmc/articles/PMC3125325/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3125325</span></a>] [<a href="/pubmed/21569298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21569298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.dad.2015.1646">Dad S, Rendtorff ND, Kann E, Albrechtsen A, Mehriouv MM, Bak M, Tommerup N, Tranebjaerg L, Rosenberg T, Jensen H, Moller LB. Partial USH2A deletions contribute to Usher syndrome in Denmark. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1646–51.</span> [<a href="/pmc/articles/PMC4795208/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4795208</span></a>] [<a href="/pubmed/25804404" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25804404</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.dreyer.2008.451">Dreyer B, Brox V, Tranebjaerg L, Rosenberg T, Sadeghi AM, M&#x000f6;ller C, Nilssen O. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:451.</span> [<a href="/pubmed/18273898" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18273898</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.dreyer.2000.500">Dreyer B, Tranebjaerg L, Rosenberg T, Weston MD, Kimberling WJ, Nilssen O. Identification of novel USH2A mutations: implications for the structure of USH2A protein. <span><span class="ref-journal">Eur J Hum Genet. </span>2000;<span class="ref-vol">8</span>:500–6.</span> [<a href="/pubmed/10909849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10909849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.ebermann.2010.1812">Ebermann I, Phillips JB, Liebau MC, Koenekoop RK, Schermer B, Lopez I, Sch&#x000e4;fer E, Roux AF, Dafinger C, Bernd A, Zrenner E, Claustres M, Blanco B, N&#x000fc;rnberg G, N&#x000fc;rnberg P, Ruland R, Westerfield M, Benzing T, Bolz HJ. PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. <span><span class="ref-journal">J Clin Invest. </span>2010;<span class="ref-vol">120</span>:1812–23.</span> [<a href="/pmc/articles/PMC2877930/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2877930</span></a>] [<a href="/pubmed/20440071" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20440071</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.ebermann.2007.203">Ebermann I, Scholl HP, Charbel Issa P, Becirovic E, Lamprecht J, Jurklies B, Mill&#x000e1;n JM, Aller E, Mitter D, Bolz H. A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss. <span><span class="ref-journal">Hum Genet. </span>2007;<span class="ref-vol">121</span>:203–11.</span> [<a href="/pubmed/17171570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17171570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.ebermann.2009.277">Ebermann I, Wiesen MH, Zrenner E, Lopez I, Pigeon R, Kohl S, Lowenheim H, Koenekoop RK, Bolz HJ. GPR98 mutations cause Usher syndrome type 2 in males. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:277–80.</span> [<a href="/pubmed/19357117" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19357117</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.eudy.1998.1753">Eudy JD, Weston MD, Yao S, Hoover DM, Rehm HL, Ma-Edmonds M, Yan D, Ahmad I, Cheng JJ, Ayuso C, Cremers C, Davenport S, Moller C, Talmadge CB, Beisel KW, Tamayo M, Morton CC, Swaroop A, Kimberling WJ, Sumegi J. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. <span><span class="ref-journal">Science. </span>1998;<span class="ref-vol">280</span>:1753–7.</span> [<a href="/pubmed/9624053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9624053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.fakin.2012.71">Fakin A, Zupan A, Glavac D, Hawlina M. Combination of retinitis pigmentosa and hearing loss caused by a novel mutation in PRPH2 and a known mutation in GJB2: importance for differential diagnosis of Usher syndrome. <span><span class="ref-journal">Vision Res. </span>2012;<span class="ref-vol">75</span>:71–6.</span> [<a href="/pubmed/22842402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22842402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.garc_agarc_a.2013.367">Garc&#x000ed;a-Garc&#x000ed;a G, Besnard T, Baux D, Vache C, Aller E, Malcolm S, Claustres M, Millan JM, Roux AF. The contribution of GPR98 and DFNB31 genes to a Spanish Usher syndrome type 2 cohort. <span><span class="ref-journal">Mol Vis. </span>2013;<span class="ref-vol">19</span>:367–73.</span> [<a href="/pmc/articles/PMC3580968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3580968</span></a>] [<a href="/pubmed/23441107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23441107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.hilgert.2009.272">Hilgert N, Kahrizi K, Dieltjens N, Bazazzadegan N, Najmabadi H, Smith RJ, Van Camp G. A large deletion in GPR98 causes type IIC Usher syndrome in male and female members of an Iranian family. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:272–6.</span> [<a href="/pmc/articles/PMC4432478/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4432478</span></a>] [<a href="/pubmed/19357116" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19357116</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.hmaniaifa.2009.474">Hmani-Aifa M, Benzina Z, Zulfiqar F, Dhouib H, Shahzadi A, Ghorbel A, Rebai A, Soderkvist P, Riazuddin S, Kimberling WJ, Ayadi H. Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:474–82.</span> [<a href="/pmc/articles/PMC2986209/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986209</span></a>] [<a href="/pubmed/18854872" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18854872</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.iannaccone.2004.784">Iannaccone A, Kritchevsky SB, Ciccarelli ML, Tedesco SA, Macaluso C, Kimberling WJ, Somes GW. Kinetics of visual field loss in Usher syndrome Type II. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2004;<span class="ref-vol">45</span>:784–92.</span> [<a href="/pubmed/14985291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14985291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.joensuu.2001.673">Joensuu T, H&#x000e4;m&#x000e4;l&#x000e4;inen R, Yuan B, Johnson C, Tegelberg S, Gasparini P, Zelante L, Pirvola U, Pakarinen L, Lehesjoki AE, de la Chapelle A, Sankila EM. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">69</span>:673–84.</span> [<a href="/pmc/articles/PMC1226054/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226054</span></a>] [<a href="/pubmed/11524702" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11524702</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.kaiserman.2008.571">Kaiserman I, Bahar I, Rootman DS. Optical coherence tomography provides insight into the effect of intacs in keratoconus. <span><span class="ref-journal">Arch Ophthalmol. </span>2008;<span class="ref-vol">126</span>:571–2.</span> [<a href="/pubmed/18413534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18413534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.kimberling.2010.512">Kimberling WJ, Hildebrand MS, Shearer AE, Jensen ML, Halder JA, Trzupek K, Cohn ES, Weleber RG, Stone EM, Smith RJ. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. <span><span class="ref-journal">Genet Med. </span>2010;<span class="ref-vol">12</span>:512–6.</span> [<a href="/pmc/articles/PMC3131500/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3131500</span></a>] [<a href="/pubmed/20613545" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20613545</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.krawitz.2014.393">Krawitz PM, Schiska D, Kruger U, Appelt S, Heinrich V, Parkhomchuk D, Timmermann B, Millan JM, Robinson PN, Mundlos S, Hecht J, Gross M. Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2014;<span class="ref-vol">2</span>:393–401.</span> [<a href="/pmc/articles/PMC4190874/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4190874</span></a>] [<a href="/pubmed/25333064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25333064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.le_quesne_stabej.2012.27">Le Quesne Stabej P, Saihan Z, Rangesh N, Steele-Stallard HB, Ambrose J, Coffey A, Emmerson J, Haralambous E, Hughes Y, Steel KP, Luxon LM, Webster AR, Bitner-Glindzicz M. Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:27–36.</span> [<a href="/pmc/articles/PMC3678402/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3678402</span></a>] [<a href="/pubmed/22135276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22135276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.leroy.2001.503">Leroy BP, Aragon-Martin JA, Weston MD, Bessant DA, Willis C, Webster AR, Bird AC, Kimberling WJ, Payne AM, Bhattacharya SS. Spectrum of mutations in USU2A in British patients with Usher syndrome type II. <span><span class="ref-journal">Exp Eye Res. </span>2001;<span class="ref-vol">72</span>:503–9.</span> [<a href="/pubmed/11311042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11311042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.liu.2007.4413">Liu X, Bulgakov OV, Darrow KN, Pawlyk B, Adamian M, Liberman MC, Li T. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2007;<span class="ref-vol">104</span>:4413–8.</span> [<a href="/pmc/articles/PMC1838616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1838616</span></a>] [<a href="/pubmed/17360538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17360538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.maerker.2008.71">Maerker T, van Wijk E, Overlack N, Kersten FF, McGee J, Goldmann T, Sehn E, Roepman R, Walsh EJ, Kremer H, Wolfrum U. A novel Usher protein network at the periciliary reloading point between molecular transport machineries in vertebrate photoreceptor cells. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:71–86.</span> [<a href="/pubmed/17906286" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17906286</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.mburu.2003.421">Mburu P, Mustapha M, Varela A, Weil D, El-Amraoui A, Holme RH, Rump A, Hardisty RE, Blanchard S, Coimbra RS, Perfettini I, Parkinson N, Mallon AM, Glenister P, Rogers MJ, Paige AJ, Moir L, Clay J, Rosenthal A, Liu XZ, Blanco G, Steel KP, Petit C, Brown SD. Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">34</span>:421–8.</span> [<a href="/pubmed/12833159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12833159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.mcmillan.2002.785">McMillan DR, Kayes-Wandover KM, Richardson JA, White PC. Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:785–92.</span> [<a href="/pubmed/11606593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11606593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.m_ller.1989.73">M&#x000f6;ller CG, Kimberling WJ, Davenport SL, Priluck I, White V, Biscone-Halterman K, Odkvist LM, Brookhouser PE, Lund G, Grissom TJ. Usher syndrome: an otoneurologic study. <span><span class="ref-journal">Laryngoscope. </span>1989;<span class="ref-vol">99</span>:73–9.</span> [<a href="/pubmed/2909824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2909824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.n_jera.2002.76">N&#x000e1;jera C, Beneyto M, Blanca J, Aller E, Fontcuberta A, Mill&#x000e1;n JM, Ayuso C. Mutations in myosin VIIA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types I and II, respectively. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">20</span>:76–7.</span> [<a href="/pubmed/12112664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12112664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.nakanishi.2011.484">Nakanishi H, Ohtsubo M, Iwasaki S, Hotta Y, Usami S, Mizuta K, Mineta H, Minoshima S. Novel USH2A mutations in Japanese Usher syndrome type 2 patients: marked differences in the mutation spectrum between the Japanese and other populations. <span><span class="ref-journal">J Hum Genet. </span>2011;<span class="ref-vol">56</span>:484–90.</span> [<a href="/pubmed/21593743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21593743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.nakayama.2002.654">Nakayama J, Fu YH, Clark AM, Nakahara S, Hamano K, Iwasaki N, Matsui A, Arinami T, Ptacek LJ. A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:654–7.</span> [<a href="/pubmed/12402266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12402266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.pearsall.2002.55">Pearsall N, Bhattacharya G, Wisecarver J, Adams J, Cosgrove D, Kimberling W. Usherin expression is highly conserved in mouse and human tissues. <span><span class="ref-journal">Hear Res. </span>2002;<span class="ref-vol">174</span>:55–63.</span> [<a href="/pubmed/12433396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12433396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.pennings.2003.525">Pennings RJ, Fields RR, Huygen PL, Deutman AF, Kimberling WJ, Cremers CW. Usher syndrome type III can mimic other types of Usher syndrome. <span><span class="ref-journal">Ann Otol Rhinol Laryngol. </span>2003;<span class="ref-vol">112</span>:525–30.</span> [<a href="/pubmed/12834121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12834121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.pennings.2004.131">Pennings RJ, Huygen PL, Orten DJ, Wagenaar M, van Aarem A, Kremer H, Kimberling WJ, Cremers CW, Deutman AF. Evaluation of visual impairment in Usher syndrome 1b and Usher syndrome 2a. <span><span class="ref-journal">Acta Ophthalmol Scand. </span>2004;<span class="ref-vol">82</span>:131–9.</span> [<a href="/pubmed/15043528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15043528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.plantinga.2005.79">Plantinga RF, Kleemola L, Huygen PL, Joensuu T, Sankila EM, Pennings RJ, Cremers CW. Serial audiometry and speech recognition findings in Finnish Usher syndrome type III patients. <span><span class="ref-journal">Audiol Neurootol. </span>2005;<span class="ref-vol">10</span>:79–89.</span> [<a href="/pubmed/15650299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15650299</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.puffenberger.2012.e28936">Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, Mahoney MH, Miller CJ, Nair DT, Politi KA, Worcester KN, Setton RA, Dipiazza R, Sherman EA, Eastman JT, Francklyn C, Robey-Bond S, Rider NL, Gabriel S, Morton DH, Strauss KA. Genetic mapping and exome sequencing identify variants associated with five novel diseases. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e28936.</span> [<a href="/pmc/articles/PMC3260153/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3260153</span></a>] [<a href="/pubmed/22279524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22279524</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.reiners.2006.97">Reiners J, Nagel-Wolfrum K, J&#x000fc;rgens K, M&#x000e4;rker T, Wolfrum U. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. <span><span class="ref-journal">Exp Eye Res. </span>2006;<span class="ref-vol">83</span>:97–119.</span> [<a href="/pubmed/16545802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16545802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.reisser.2002.1108">Reisser CF, Kimberling WJ, Otterstedde CR. Hearing loss in Usher syndrome type II is nonprogressive. <span><span class="ref-journal">Ann Otol Rhinol Laryngol. </span>2002;<span class="ref-vol">111</span>:1108–11.</span> [<a href="/pubmed/12498372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12498372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.rivolta.2000.1975">Rivolta C, Sweklo EA, Berson EL, Dryja TP. Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1975–8.</span> [<a href="/pmc/articles/PMC1378039/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1378039</span></a>] [<a href="/pubmed/10775529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10775529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.sadeghi.2004.136">Sadeghi M, Cohn ES, Kelly WJ, Kimberling WJ, Tranebjaerg L, Moller C. Audiological findings in Usher syndrome types IIa and II (non-IIa). <span><span class="ref-journal">Int J Audiol. </span>2004;<span class="ref-vol">43</span>:136–43.</span> [<a href="/pubmed/15198377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15198377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.schneider.2009.655">Schneider E, M&#x000e4;rker T, Daser A, Frey-Mahn G, Beyer V, Farcas R, Schneider-R&#x000e4;tzke B, Kohlschmidt N, Grossmann B, Bauss K, Napiontek U, Keilmann A, Bartsch O, Zechner U, Wolfrum U, Haaf T. Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:655–66.</span> [<a href="/pubmed/19028668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19028668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.schwartz.2005.734">Schwartz SB, Aleman TS, Cideciyan AV, Windsor EA, Sumaroka A, Roman AJ, Rane T, Smilko EE, Bennett J, Stone EM, Kimberling WJ, Liu XZ, Jacobson SG. Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2005;<span class="ref-vol">46</span>:734–43.</span> [<a href="/pubmed/15671307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15671307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.seyedahmadi.2004.167">Seyedahmadi BJ, Rivolta C, Keene JA, Berson EL, Dryja TP. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. <span><span class="ref-journal">Exp Eye Res. </span>2004;<span class="ref-vol">79</span>:167–73.</span> [<a href="/pubmed/15325563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15325563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.skradski.2001.537">Skradski SL, Clark AM, Jiang H, White HS, Fu YH, Pt&#x000e1;cek LJ. A novel gene causing a mendelian audiogenic mouse epilepsy. <span><span class="ref-journal">Neuron. </span>2001;<span class="ref-vol">31</span>:537–44.</span> [<a href="/pubmed/11545713" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11545713</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.sodi.2014.1717">Sodi A, Mariottini A, Passerini I, Murro V, Tachyla I, Bianchi B, Menchini U, Torricelli F. MYO7A and USH2A gene sequence variants in Italian patients with Usher syndrome. <span><span class="ref-journal">Molecular Vision. </span>2014;<span class="ref-vol">20</span>:1717–31.</span> [<a href="/pmc/articles/PMC4279600/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4279600</span></a>] [<a href="/pubmed/25558175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25558175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.spandau.2002.495">Spandau UH, Rohrschneider K. Prevalence and geographical distribution of Usher syndrome in Germany. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>2002;<span class="ref-vol">240</span>:495–8.</span> [<a href="/pubmed/12107518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12107518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.steelestallard.2013.122">Steele-Stallard HB, Le Quesne Stabej P, Lenassi E, Luxon LM, Claustres M, Roux AF, Webster AR, Bitner-Glindzicz M. Screening for duplications, deletions and a common intronic mutation detects 35% of second mutations in patients with USH2A monoallelic mutations on Sanger sequencing. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2013;<span class="ref-vol">8</span>:122.</span> [<a href="/pmc/articles/PMC3751126/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3751126</span></a>] [<a href="/pubmed/23924366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23924366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.tlili.2005.503">Tlili A, Charfedine I, Lahmar I, Benzina Z, Mohamed BA, Weil D, Idriss N, Drira M, Masmoudi S, Ayadi H. Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:503.</span> [<a href="/pubmed/15841483" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15841483</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.vach_.2012.104">Vach&#x000e9; C, Besnard T, le Berre P, Garc&#x000ed;a-Garc&#x000ed;a G, Baux D, Larrieu L, Abadie C, Blanchet C, Bolz H, Millan J, Hamel C, Malcolm S, Claustres M, Roux A. Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy. <span><span class="ref-journal">Hum Mutat. </span>2012;<span class="ref-vol">33</span>:104–8.</span> [<a href="/pubmed/22009552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22009552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.van_wijk.2004.738">van Wijk E, Pennings RJ, te Brinke H, Claassen A, Yntema HG, Hoefsloot LH, Cremers FP, Cremers CW, Kremer H. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:738–44.</span> [<a href="/pmc/articles/PMC1181950/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181950</span></a>] [<a href="/pubmed/15015129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15015129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.van_wijk.2006.751">van Wijk E, van der Zwaag B, Peters T, Zimmermann U, Te Brinke H, Kersten FF, M&#x000e4;rker T, Aller E, Hoefsloot LH, Cremers CW, Cremers FP, Wolfrum U, Knipper M, Roepman R, Kremer H. The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1. <span><span class="ref-journal">Hum Mol Genet. </span>2006;<span class="ref-vol">15</span>:751–65.</span> [<a href="/pubmed/16434480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16434480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.v_stinsalo.2011.30">V&#x000e4;stinsalo H, Jalkanen R, Dinculescu A, Isosomppi J, Geller S, Flannery JG, Hauswirth WW, Sankila EM. Alternative splice variants of the USH3A gene Clarin 1 (CLRN1). <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:30–5.</span> [<a href="/pmc/articles/PMC3039507/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3039507</span></a>] [<a href="/pubmed/20717163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20717163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.weston.2000.1199">Weston MD, Eudy JD, Fujita S, Yao S, Usami S, Cremers C, Greenberg J, Ramesar R, Martini A, Moller C, Smith RJ, Sumegi J, Kimberling WJ. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:1199–210.</span> [<a href="/pmc/articles/PMC1288187/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288187</span></a>] [<a href="/pubmed/10729113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10729113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.weston.2004.357">Weston MD, Luijendijk MW, Humphrey KD, M&#x000f6;ller C, Kimberling WJ. Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:357–66.</span> [<a href="/pmc/articles/PMC1181933/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181933</span></a>] [<a href="/pubmed/14740321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14740321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.xu.2011.1537">Xu W, Dai H, Lu T, Zhang X, Dong B, Li Y. Seven novel mutations in the long isoform of the USH2A gene in Chinese families with nonsyndromic retinitis pigmentosa and Usher syndrome type II. <span><span class="ref-journal">Mol Vis. </span>2011;<span class="ref-vol">17</span>:1537–52.</span> [<a href="/pmc/articles/PMC3115748/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3115748</span></a>] [<a href="/pubmed/21686329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21686329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.yang.2010.e1000955">Yang J, Liu X, Zhao Y, Adamian M, Pawlyk B, Sun X, McMillan DR, Liberman MC, Li T. Ablation of whirlin long isoform disrupts the USH2 protein complex and causes vision and hearing loss. <span><span class="ref-journal">PLoS Genet. </span>2010;<span class="ref-vol">6</span>:e1000955.</span> [<a href="/pmc/articles/PMC2873905/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2873905</span></a>] [<a href="/pubmed/20502675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20502675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="usher2.REF.zou.2011.2343">Zou J, Luo L, Shen Z, Chiodo V, Ambati B, Hauswirth W, Yang J. Whirlin replacement restores the formation of the USH2 protein complex in whirlin knockout photoreceptors. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2011;<span class="ref-vol">52</span>:2343–51.</span> [<a href="/pmc/articles/PMC3081228/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3081228</span></a>] [<a href="/pubmed/21212183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21212183</span></a>]</div></li></ul></div></div><div id="usher2.Chapter_Notes"><h2 id="_usher2_Chapter_Notes_">Chapter Notes</h2><div id="usher2.Acknowledgments"><h3>Acknowledgments</h3><p>Edward Cohn, MD, Department of Otolaryngology, Boys Town National Research Hospital</p><p>Janos Sumegi, PhD, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha</p><p>Claes M&#x000f6;ller, MD, PhD, Department of Otorhinolaryngology, Sahlgrenska University Hospital, G&#x000f6;teborg, Sweden</p><p>Research supported by FFB and NIH</p></div><div id="usher2.Author_History"><h3>Author History</h3><p>Bronya Keats, PhD (2006-present)<br />William J Kimberling, PhD, FACMG; Boys Town National Research Hospital (1999-2006)<br />Jennifer Lentz, PhD (2006-present)<br />Dana J Orten, PhD; Boys Town National Research Hospital (2003-2006)<br />Sandra Pieke-Dahl, PhD; Ohio State University (1999-2003)<br />Michael D Weston, MA; Boys Town National Research Hospital (1999-2006)</p></div><div id="usher2.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 July 2016 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 August 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 December 2011 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available for <i>GPR98</i> and <i>DFNB31</i></div></li><li class="half_rhythm"><div>23 December 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 April 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 November 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for Usher syndrome type 2A available</div></li><li class="half_rhythm"><div>14 November 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 October 2004 (wk) Revision: sequencing of entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> available</div></li><li class="half_rhythm"><div>13 January 2004 (wk) Revision: change in test availability</div></li><li class="half_rhythm"><div>20 November 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 December 1999 (me) Review posted live</div></li><li class="half_rhythm"><div>19 February 1999 (wk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1341</span><span class="label">PMID: <a href="/pubmed/20301515" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301515</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/usher1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/wagner/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1341&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1341/?report=reader">PubReader</a></li><li><a href="/books/NBK1341/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1341" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1341" style="display:none" title="Cite this Page"><div class="bk_tt">Lentz J, Keats B. Usher Syndrome Type II. 1999 Dec 10 [Updated 2016 Jul 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1341/pdf/Bookshelf_NBK1341.pdf">PDF version of this page</a> (248K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#usher2.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#usher2.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#usher2.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#usher2.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#usher2.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#usher2.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#usher2.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#usher2.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#usher2.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#usher2.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#usher2.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=79955[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PDZD7</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=25861[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">WHRN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7399[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">USH2A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=84059[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ADGRV1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1341+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1474518" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1474518" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1474518" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1474518" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301442" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Usher Syndrome Type I</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Usher Syndrome Type I<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lentz J, Keats BJB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17171570" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.</a><span class="source">[Hum Genet. 2007]</span><div class="brieflinkpop offscreen_noflow">A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ebermann I, Scholl HP, Charbel Issa P, Becirovic E, Lamprecht J, Jurklies B, Millán JM, Aller E, Mitter D, Bolz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Genet. 2007 Apr; 121(2):203-11. Epub 2006 Dec 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31046701" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Novel Usher syndrome pathogenic variants identified in cases with hearing and vision loss.</a><span class="source">[BMC Med Genet. 2019]</span><div class="brieflinkpop offscreen_noflow">Novel Usher syndrome pathogenic variants identified in cases with hearing and vision loss.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pater JA, Green J, O'Rielly DD, Griffin A, Squires J, Burt T, Fernandez S, Fernandez B, Houston J, Zhou J, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Med Genet. 2019 May 2; 20(1):68. Epub 2019 May 2.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21234346" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">An update on the genetics of usher syndrome.</a><span class="source">[J Ophthalmol. 2011]</span><div class="brieflinkpop offscreen_noflow">An update on the genetics of usher syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Millán JM, Aller E, Jaijo T, Blanco-Kelly F, Gimenez-Pardo A, Ayuso C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Ophthalmol. 2011; 2011:417217. Epub 2010 Dec 23.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16545802" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.</a><span class="source">[Exp Eye Res. 2006]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Reiners J, Nagel-Wolfrum K, Jürgens K, Märker T, Wolfrum U. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Exp Eye Res. 2006 Jul; 83(1):97-119. Epub 2006 Mar 20.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301515" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301515" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04117275f66d18aae2ead3">Usher Syndrome Type II - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Usher Syndrome Type II - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:48:34-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AF730E041023100000000009A002B&amp;ncbi_session=CE8AF730E0411711_0154SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1341%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1341&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1341/&amp;ncbi_pagename=Usher Syndrome Type II - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AF730E0411711_0154SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>